PANGeA - Physical Activity and Nutrition for Quality Ageing (PANGeA_MM)

May 21, 2021 updated by: Rado Pisot, Science and Research Centre Koper

Longitudinal PANGeA Mass Measurement - Physical Activity and Nutrition for Quality Ageing

General objectives of the project

Defining healthy ageing factors; Setting up content-related bases of the international excellence centre (SLO-ITA) in the field of health of elderly citizens; Raising awareness on the significance of healthy ageing, social inclusion and mobility of less privileged populations (the elderly); Reducing the costs of health care; Connecting the existing health care, social and private entities and improving their mutual coordination.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Physical activity, dietary habits, social and private entities strongly affect the quality of health and quality of life of the elderly. The main object of this study will be to evaluate physical and cognitive performance in combination with physical activity and dietary habits of the elderly. The investigators are interested in longitudinal monitoring of the elderly that participated in measurements in 2013 and measurements after a decade. The results of this study will give important epidemiological information about physical and cognitive status, health status in combination with physical activity which occurs in a longer period of time.

Study Type

Observational

Enrollment (Anticipated)

950

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All males and females who participated in PANGeA mass measurements in 2013 will bi considered in the study.

Description

Inclusion Criteria:

  • singed written consent
  • age above 60
  • healthy

Exclusion Criteria:

  • severe musculoskeletal injuries
  • inability to follow instructions when performing the test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Longitudinal observation
No specific intervention, pre-post measurements only
Other: Longitudinal observation
No specific intervention, longitudinal (pre-post measurements) only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grip strength
Time Frame: change in grip strength between two observational time points (pre-post 8-10years)
Grip strength measured using a hand-held dynamometer
change in grip strength between two observational time points (pre-post 8-10years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait speed
Time Frame: change in gait speed between two observational time points (pre-post 8-10years)
Gait speed measured for four meters self selected speed
change in gait speed between two observational time points (pre-post 8-10years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Science and Research Centre Koper

Investigators

  • Study Director: Rado Pisot, PhD, Science and Research Centre Koper

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2013

Primary Completion (Anticipated)

April 1, 2023

Study Completion (Anticipated)

April 1, 2023

Study Registration Dates

First Submitted

May 19, 2021

First Submitted That Met QC Criteria

May 19, 2021

First Posted (Actual)

May 24, 2021

Study Record Updates

Last Update Posted (Actual)

May 25, 2021

Last Update Submitted That Met QC Criteria

May 21, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PANGeA MM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on Longitudinal observation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe